Vasconcellos C A, Lind S E
Experimental Medicine Division, Brigham and Women's Hospital, Boston, MA 02115.
Blood. 1993 Dec 15;82(12):3648-57.
Actin is an abundant intracellular protein that is released into the blood during tissue injury and its injection into rats causes microthrombi to form in the vasculature. This report and others have shown that actin filaments are able to aggregate platelets in an adenosine diphosphate (ADP)-dependent manner. The effects on this process of two plasma actin-binding proteins, vitamin D-binding protein (DBP) and gelsolin, were examined separately and together. The addition of DBP, a monomer-binding protein, to actin filaments did not affect their ability to induce platelet aggregation. However, severing of actin filaments with gelsolin resulted in an increased degree of platelet aggregation. Preincubation of F-actin with both gelsolin and DBP resulted in a significant inhibition of aggregation. The effects of DBP and gelsolin on actin-induced aggregation paralleled their effects on exchange of actin-bound adenine nucleotides. DBP inhibited 1, N6-ethenoadenosine 5' triphosphate (epsilon-ATP) exchange with G-actin but not with F-actin. Gelsolin increased epsilon-ATP exchange with F-actin, which was largely abrogated by the addition of DBP. These results suggest that gelsolin's severing (and subsequent capping) of actin filaments not only results in an increase in the number of pointed filament ends but also in the dissociation of actin monomers containing ADP. Phalloidin, which stabilizes actin filaments while decreasing both monomer and nucleotide exchange, inhibited actin-induced aggregation, as well, indicating that depolymerization of actin filaments is not required to inhibit aggregation. Platelet activation by either G- or F-actin may thus be regulated by the local concentrations of the plasma actin-binding proteins gelsolin and DBP. Together, these proteins inhibit platelet aggregation in a manner that can be explained by their effects on actin's filament structure and the accessibility of its bound ADP. Depletion of DBP or gelsolin may allow actin released from injured tissues to stimulate purinergic receptors on platelets, and perhaps other cells, via its bound adenine nucleotides.
肌动蛋白是一种丰富的细胞内蛋白质,在组织损伤时会释放到血液中,将其注射到大鼠体内会导致血管中形成微血栓。本报告及其他研究表明,肌动蛋白丝能够以二磷酸腺苷(ADP)依赖的方式聚集血小板。分别及共同研究了两种血浆肌动蛋白结合蛋白,即维生素D结合蛋白(DBP)和凝溶胶蛋白,对这一过程的影响。向肌动蛋白丝中添加单体结合蛋白DBP并不影响其诱导血小板聚集的能力。然而,用凝溶胶蛋白切断肌动蛋白丝会导致血小板聚集程度增加。F-肌动蛋白与凝溶胶蛋白和DBP共同预孵育会导致聚集显著受到抑制。DBP和凝溶胶蛋白对肌动蛋白诱导聚集的影响与其对肌动蛋白结合腺嘌呤核苷酸交换的影响相似。DBP抑制1,N6-乙烯腺苷5'-三磷酸(ε-ATP)与G-肌动蛋白的交换,但不抑制与F-肌动蛋白的交换。凝溶胶蛋白增加了ε-ATP与F-肌动蛋白的交换,添加DBP后这种增加在很大程度上被消除。这些结果表明,凝溶胶蛋白对肌动蛋白丝的切断(以及随后的封端)不仅导致尖状丝末端数量增加,还导致含有ADP的肌动蛋白单体解离。鬼笔环肽可稳定肌动蛋白丝,同时减少单体和核苷酸交换,它也抑制肌动蛋白诱导的聚集,这表明抑制聚集并不需要肌动蛋白丝解聚。因此,G-肌动蛋白或F-肌动蛋白对血小板的激活可能受血浆肌动蛋白结合蛋白凝溶胶蛋白和DBP的局部浓度调节。这些蛋白质共同以一种可以通过其对肌动蛋白丝结构及其结合的ADP可及性的影响来解释的方式抑制血小板聚集。DBP或凝溶胶蛋白的耗竭可能使损伤组织释放的肌动蛋白通过其结合的腺嘌呤核苷酸刺激血小板以及可能其他细胞上的嘌呤能受体。